Marshall Wace
COLL icon

Marshall Wace’s Collegium Pharmaceutical COLL Stock Holding History

Marshall Wace’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.8M Buy
748,812
+256,452
+52% +$10.9M 0.02% 621
2025
Q4 		$22.8M Buy
492,360
+213,347
+76% +$8.93M 0.02% 591
2025
Q3 		$9.76M Buy
279,013
+142,292
+104% +$4.95M 0.01% 925
2025
Q2 		$4.04M Buy
+136,721
New +$3.9M ﹤0.01% 1250
2024
Q3 		– Sell
-70,964
Closed -$2.29M – 2564
2024
Q2 		$2.29M Buy
+70,964
New +$2.46M ﹤0.01% 1304
2024
Q1 		– Sell
-136,049
Closed -$4.19M – 2492
2023
Q4 		$4.19M Sell
136,049
-250,247
-65% -$6.27M 0.01% 969
2023
Q3 		$8.63M Sell
386,296
-108,180
-22% -$2.47M 0.02% 693
2023
Q2 		$10.6M Sell
494,476
-85,435
-15% -$1.94M 0.02% 708
2023
Q1 		$13.9M Buy
579,911
+272,881
+89% +$7.24M 0.03% 595
2022
Q4 		$7.12M Buy
307,030
+267,065
+668% +$5.39M 0.02% 993
2022
Q3 		$640K Buy
+39,965
New +$705K ﹤0.01% 2621
2021
Q3 		– Sell
-11,718
Closed -$277K – 3069
2021
Q2 		$277K Buy
+11,718
New +$271K ﹤0.01% 2350
2019
Q2 		– Sell
-56,961
Closed -$862K – 1422
2019
Q1 		$862K Buy
+56,961
New +$912K 0.01% 981

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Marshall Wace's COLL Position: Q1 2026 in Review

Marshall Wace increased its Collegium Pharmaceutical (COLL) stake by 52% in Q1 2026, buying an estimated $10.9M and bringing the position to 748,812 shares worth $24.8M. The position accounts for 0.02% of the portfolio, ranked #621.

Marshall Wace first reported a position in COLL in Q1 2019 and has held it in 13 quarters since. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Marshall Wace held 748,812 shares of Collegium Pharmaceutical worth $24.8M as of Q1 2026.
  • Marshall Wace bought 256,452 Collegium Pharmaceutical shares in Q1 2026, an estimated $10.9M.
  • Collegium Pharmaceutical made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #621 holding.
  • Marshall Wace first reported a position in Collegium Pharmaceutical in Q1 2019 and has held it in 13 quarters since.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.